ARCH Venture Fund XIII, L.P. - Insider Trading & Ownership

Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated value of insider holdings of ARCH Venture Fund XIII, L.P. is at least $375K dollars as of July 29, 2025. ARCH Venture Fund XIII, L.P. is the 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $375K.
Signature
ARCH Venture Partners XIII, LLC, By: /s/ Mark McDonnell, as Attorney-in-Fact for Keith Crandell, Managing Director
All Insider Reports
All Insider Reports

Ownership of ARCH Venture Fund XIII, L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LYEL Lyell Immunopharma, Inc. 10%+ Owner $375K Jul 25, 2025

There are no insider transactions reported by ARCH Venture Fund XIII, L.P.